Why GSK Stock Rocketed Nearly 6% Skyward on Wednesday

Source The Motley Fool

Thanks largely to news of a crucial legal settlement, GSK (NYSE: GSK) was one of the better-performing big pharma stocks on Wednesday. Relieved investors showed their appreciation by collectively bidding the company's shares up by 5.8% on the day, a performance that easily eclipsed the 0.7% rise of the benchmark S&P 500 index.

$2.2 billion-plus in settlements

That news concerns a discontinued version of GSK's blockbuster heartburn drug Zantac, which was the focus of a series of lawsuits alleging that its active ingredient caused cancer. GSK announced Wednesday that it has agreed to a settlement with 10 plaintiffs' law firms representing around 80,000 Zantac cases -- 93% of the total number. The agreement will see the pharmaceutical company make a maximum aggregate payment of $2.2 billion to resolve all of those cases.

GSK added that other terms of the settlement were confidential. The company wrote that it expects the settlement to be fully implemented by the end of the first half of 2025.

Additionally, GSK has agreed in principle to settle a whistleblower lawsuit brought by Valisure, a laboratory based in Connecticut, with a $70 million payment. Similar to the cases in the other settlement, Valisure had accused the company of concealing the risks of cancer associated with Zantac.

Not admitting liability

At one point, the heavily marketed Zantac was the best-selling drug in the world. First approved in the U.S. in 1983, its long run ended in 2020 when the Food and Drug Administration asked its makers to remove it from the market. This was on concerns that the active ingredient, ranitidine, could degenerate into a carcinogenic substance under certain circumstances.

In its press release on the settlements, GSK stressed that it has not admitted liability in either instance.

It added, "While the scientific consensus remains that there is no consistent or reliable evidence that ranitidine increases the risk of any cancer, GSK strongly believes that these settlements are in the best long-term interests of the company and its shareholders, as they remove significant financial uncertainty, risk, and distraction associated with protracted litigation."

Don’t miss this second chance at a potentially lucrative opportunity

Ever feel like you missed the boat in buying the most successful stocks? Then you’ll want to hear this.

On rare occasions, our expert team of analysts issues a “Double Down” stock recommendation for companies that they think are about to pop. If you’re worried you’ve already missed your chance to invest, now is the best time to buy before it’s too late. And the numbers speak for themselves:

  • Amazon: if you invested $1,000 when we doubled down in 2010, you’d have $20,579!*
  • Apple: if you invested $1,000 when we doubled down in 2008, you’d have $42,710!*
  • Netflix: if you invested $1,000 when we doubled down in 2004, you’d have $389,239!*

Right now, we’re issuing “Double Down” alerts for three incredible companies, and there may not be another chance like this anytime soon.

See 3 “Double Down” stocks »

*Stock Advisor returns as of October 7, 2024

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool recommends GSK. The Motley Fool has a disclosure policy.

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
EURUSD Long-term Forecast: Can ECB Hawks Overcome the Dollar Bullishness? As one of the most traded currency pair in the forex markets, the price of EURUSD affects many traders. Check out our EURUSD long-term forecast for more information.
Author  Mitrade
Mar 13, 2023
As one of the most traded currency pair in the forex markets, the price of EURUSD affects many traders. Check out our EURUSD long-term forecast for more information.
placeholder
Copper Long-term forecast: Will Copper Price Expected To Soar In 2023?The price of copper is affected by various of factors. You may wonder how the price of cooper will be in 2023, check out our forecast analysis.
Author  Mitrade
Mar 13, 2023
The price of copper is affected by various of factors. You may wonder how the price of cooper will be in 2023, check out our forecast analysis.
placeholder
Bitcoin CME gaps at $35,000, $27,000 and $21,000, which one gets filled first?Prioritize filling the $27,000 gap and even try higher.
Author  FXStreet
Aug 21, 2023
Prioritize filling the $27,000 gap and even try higher.
placeholder
Natural Gas sinks to pivotal level as China’s demand slumpsNatural Gas price (XNG/USD) edges lower and sinks to $2.56 on Monday, extending its losing streak for the fifth day in a row. The move comes on the back of China cutting its Liquified Natural Gas (LNG) imports after prices rose above $3.0 in June. It
Author  FXStreet
Jul 01, Mon
Natural Gas price (XNG/USD) edges lower and sinks to $2.56 on Monday, extending its losing streak for the fifth day in a row. The move comes on the back of China cutting its Liquified Natural Gas (LNG) imports after prices rose above $3.0 in June. It
placeholder
Why Trump Media Stock Is Plummeting TodayDespite Donald Trump's victory in the presidential election, Trump Media stock is losing ground today. While there isn't any new business-specific news for the company or unfavorable political developments for Donald Trump, the social media specialist's share price is moving lower as investors move to take profits on the stock.
Author  The Motley Fool
Nov 08, Fri
Despite Donald Trump's victory in the presidential election, Trump Media stock is losing ground today. While there isn't any new business-specific news for the company or unfavorable political developments for Donald Trump, the social media specialist's share price is moving lower as investors move to take profits on the stock.
goTop
quote